Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-001287

Chief Executive Officer acquired 103,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2025-01-07 Grant or award +103,750 224,445 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2025-01-07 Grant or award · Stock Option (right to buy) +207,500 207,500 D: show line 2 in the form
Loading xslF345X05/form4-01102025_040110.xml…